US has more than 9 million Johnson & Johnson doses ready to go if pause lifts

  • 📰 CNN Philippines
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 63%

Philippines Headlines News

Philippines Latest News,Philippines Headlines

The US has more than 9 million doses of Johnson & Johnson's coronavirus vaccine ready to be administered if federal health officials lift their recommended pause of the one-shot vaccine, CNN has learned.

President Joe Biden's coronavirus adviser Jeff Zients told CNN there are more than 9 million doses that have already been distributed to states, tribes, territories and federal channels that are ready to go, depending on the conclusion reached by the US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices -- a panel weighing whether to recommend a change in federal guidance on the vaccine.

And later on Friday, a week and a half after the pause, the ACIP is expected to vote on any changes to its guidance for the Johnson & Johnson vaccine. If the committee recommends changes to the vaccine label -- such as a warning, or changes to who it recommends should get the vaccine -- CDC Director Dr. Rochelle Walensky will sign off and then the FDA will have to make any label changes.

The CDC has learned of 15 cases of a rare blood clotting condition called thrombocytopenia syndrome linked with Johnson & Johnson's coronavirus vaccine, an expert told CDC vaccine advisers Friday. So far, patients with TTS linked with Johnson & Johnson's coronavirus vaccine have started showing symptoms one to two weeks after getting the vaccine, Shimabukuro said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 13. in PH

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.